Molecular genetic causes of epilepsy in children

Yanin K.R.; Gumeniuk O.I.; Korotkov A.G.; Yanina T.A.

doi:https://doi.org/10.17116/jnevro202412411260

Recommended articles:

Febrile infection-related epilepsy syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7):34-40

Abstract:

The molecular genetic approach to the study of epilepsy in childhood allows us to come closer to understanding the role of heredity in the development of epilepsy, as well as provide a personalized approach to the treatment and rehabilitation of severe, often resistant forms of epilepsy. In this article we demonstrate the genetic factors that cause the development of epilepsy in children. The review is devoted to the most common mechanisms of development of genetic epilepsies.

Keywords:

genetic epilepsy

epileptic syndrome

de novo mutations

epilepsy in children

Authors:

Yanin K.R.

Razumovsky Saratov State Medical University

ORCID: 0009-0001-4462-8153

Gumeniuk O.I.

Razumovsky Saratov State Medical University

ORCID: 0000-0001-5736-9624

Korotkov A.G.

Razumovsky Saratov State Medical University

ORCID: 0009-0001-3447-9158

Yanina T.A.

Branch of Gazprom Transgaz Saratov LLC «Medical and Sanitary Unit»

ORCID: 0009-0006-5398-1748

Received:

04.05.2024

Accepted:

20.09.2024

Close metadata

References:

Guerreiro CA. Epilepsy: Is there hope? The Indian journal of medical research, 2016;144(5), 657-660. https://doi.org/10.4103/ijmr.IJMR_1051_16
Blinov DV. Epilepsy syndromes: the 2022 ILAE definition and classification. Epilepsia i paroksizmalʹnye sostoania/Epilepsy and Paroxysmal Conditions. 2022;14 (2):101-182 (In Russ.). https://doi.org/10.17749/2077-8333/epi.par.con.2022.123
Hebbar, M., & Mefford, H. C. Recent advances in epilepsy genomics and genetic testing. F1000Research, 2020 Mar 12;9:F1000 Faculty Rev-185. https://doi.org/10.12688/f1000research.21366.1
Gamirova RG, Gamirova RR, Esin RG. Genetics of epilepsy: successes, problems and development prospects. S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(9):144-150. (In Russ.). https://doi.org/10.17116/jnevro2020120091144
Bayat A, Bayat M, Rubboli G, et al. Epilepsy Syndromes in the First Year of Life and Usefulness of Genetic Testing for Precision Therapy. Genes (Basel). 2021;12(7):1051. https://doi.org/10.3390/genes12071051
Sisodiya SM. Precision medicine and therapies of the future. Epilepsia. 2021;62 Suppl 2(Suppl 2):S90-S105. https://doi.org/10.1111/epi.16539
Symonds JD, McTague A. Epilepsy and developmental disorders: Next generation sequencing in the clinic. Eur J Paediatr Neurol. 2020;24:15-23. https://doi.org/10.1016/j.ejpn.2019.12.008
Potyatishin A.E. Epilepticheskie i neepilepticheskie sindromy u detej grudnogo vozrasta. Izdatel’stvo SpecLit; 2022. (In Russ.).
Zuberi, S. M., Wirrell, E., Yozawitz, E.,et al. ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: Position statement by the ILAE Task Force on Nosology and Definitions. Epilepsia, 2022;63(6):1349-1397. https://doi.org/10.1111/epi.17239
Bugun OV, Martynovich NN, Bogonosova GP, et al. Inherited metabolic diseases: Aminoacidopathies, organic acidemia, defects of mitochondrial β-oxidation. A brief overview. Acta biomedica scientifica. 2021;6(5):112-125. (In Russ.). https://doi.org/10.29413/abs.2021-6.5.11
Shchederkina IO, Livshtz MI, Kuzmina EV, et al. Sturge—Weber syndrome in children. Clinical features, diagnosis and approaches to therapy on the example of three clinical cases. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(11-2):55-64. (In Russ.). https://doi.org/10.17116/jnevro201911911255
Mukhin KYu, Pylaeva OA, Bobylova MYu, et al. Genetic epilepsy caused by CDKL5 gene mutations as an example of epileptic encephalopathy and developmental encephalopathy: literature review and own observations. Russkiy zhurnal detskoy nevrologii=Russian Journal of Child Neurology. 2021;16(1-2):10-41. (In Russ.). https://doi.org/10.17650/2073-8803-2021-16-1-2-10-41
Kulish EA, Kotov AS, Mukhina EV et al. Glucose transporter deficiency syndrome type 1: a case report. Russkiy zhurnal detskoy nevrologii=Russian Journal of Child Neurology. 2019;14(2):23-28. (In Russ.). https://doi.org/10.17650/2073-8803-2019-14-2-23-28
Gamirova RG, Afawi Z, Gamirova RR, et al. Glucose Transporter 1 deficiency and associated conditions in children. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2019;64(5):155-158. (In Russ.). https://doi.org/10.21508/1027-4065-2019-64-5-155-158
Specchio N, Ferretti A, Trivisano M, et al. Neuronal Ceroid Lipofuscinosis: Potential for Targeted Therapy. Drugs. 2021;81(1):101-123. https://doi.org/10.1007/s40265-020-01440-7
Naseri N, Sharma M, Velinov M. Autosomal dominant neuronal ceroid lipofuscinosis: Clinical features and molecular basis. Clin Genet. 2021;99(1):111-118. https://doi.org/10.1111/cge.13829
Ivanov VP, Satanin LA, Kim AV et al. Neurological and Neurosurgical Aspects of Hypophosphatasia. Pediatricheskaya farmakologiya — Pediatric pharmacology. 2018;15(3):249-254. (In Russ.). https://doi.org/10.15690/pf.v15i3.1905
Wassenberg T, Molero-Luis M, Jeltsch K, et al. Consensus guideline for the diagnosis and treatment of aromatic l-amino acid decarboxylase (AADC) deficiency. Orphanet J Rare Dis. 2017;12(1):12. https://doi.org/10.1186/s13023-016-0522-z
Kotov AS, Firsov KV. Epilepsy in mitochondrial diseases. Clinical lecture. Russian Journal of Child Neurology. 2022;17(4):63-70. (In Russ.). https://doi.org/10.17650/2073-8803-2022-17-4-63-70
Nikolaeva EA. Diagnostics and prevention of nuclear-encoded mitochondrial diseases in infants. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2014;59(2):19-28. (In Russ.).
Gonchar MA, Muratov GR, Logvinova OL, et al. Peroxisomal biogenesis disorders in Zellweger syndrome spectrum: diagnosis, monitoring and treatment according to the recommendations of the Global Foundation for Peroxisomal Disorders. Zdorov’e Rebenka. 2018;13(2):194-203. (In Russ.).
PD’Gama AM, Mulhern S, Sheidley BR, et al. Gene-STEPS Study Group; IPCHiP Executive Committee. Evaluation of the feasibility, diagnostic yield, and clinical utility of rapid genome sequencing in infantile epilepsy (Gene-STEPS):an international, multicentre, pilot cohort study. Lancet Neurol. 2023;22(9):812-825. https://doi.org/10.1016/S1474-4422(23)00246-6
Knowles JK, Helbig I, Metcalf CS, et al. Precision medicine for genetic epilepsy on the horizon: Recent advances, present challenges, and suggestions for continued progress. Epilepsia. 2022;63(10):2461-2475. https://doi.org/10.1111/epi.17332
McKnight D, Morales A, Hatchell KE, et al. Genetic Testing to Inform Epilepsy Treatment Management From an International Study of Clinical Practice. JAMA Neurol. 2022;79(12):1267-1276. https://doi.org/10.1001/jamaneurol.2022.3651
Kaplan DI, Isom LL, Petrou S. Role of Sodium Channels in Epilepsy. Cold Spring Harb Perspect Med. 2016;6(6):a022814. https://doi.org/10.1101/cshperspect.a022814
Villa C, Combi R. Potassium Channels and Human Epileptic Phenotypes: An Updated Overview. Front Cell Neurosci. 2016;10:81. https://doi.org/10.3389/fncel.2016.00081
Rochtus A, Olson HE, Smith L, et al. Genetic diagnoses in epilepsy: The impact of dynamic exome analysis in a pediatric cohort. Epilepsia. 2020;61(2):249-258. https://doi.org/10.1111/epi.16427
Afawi Z, Gamirova RG, Jaxybayeva AKh, et al. Modern achievements in genetic studies of idiopathic generalized epilepsies. S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(10-2):56-60. (In Russ.). https://doi.org/10.17116/jnevro201811810256
McCormack M, McGinty RN, Zhu X, et al. De-novo mutations in patients with chronic ultra-refractory epilepsy with onset after age five years. Eur J Med Genet. 2020;63(1):103625. https://doi.org/10.1016/j.ejmg.2019.01.015
Mukhin KYu. Focal cortical dysplasia:clinical-electro-neuroimaging characteristics. Russkij Zhurnal Detskoj Nevrologii. 2016;11(2):8-24. (In Russ.). https://doi.org/10.17650/2073-8803-2016-11-2-8-24
Mukhin KYu, Pylaeva OA. Modern approaches in the treatment of Lennox-gastaut syndrome (a review of literature). Russian Journal of Child Neurology. 2018;13(2):34-57. (In Russ.). https://doi.org/10.17650/2073-8803-2018-13-2-34-57
Mukhin K.Yu., Pylaeva O.A. New classification of epileptic syndromes of the International Antiepileptic League (2022): basic definitions and principles; differences from the draft classification; comments and discussions. Bulletin of Epileptology. 2022;1:4-14.
Kulikova SL, Likhachev SA, Zaitsev II, et al. Epileptic encephalopathy in monogenic epilepsies in children:the current state of the problem. Meditsinskie novosti. 2018;1(280):36-40. (In Russ.).
Akhmadeeva LR, Vashkevich AG, Vorontsova LM. Ohtahara II sydrome as a rare epileptic encephalopathy (a case report). Saratov Journal of Medical Scientific Research. 2018;14 (1):123-126. (In Russ.).
Spoto G, Saia MC, Amore G, et al. Neonatal Seizures: An Overview of Genetic Causes and Treatment Options. Brain Sci. 2021;11(10):1295. https://doi.org/10.3390/brainsci11101295
Beal JC, Cherian K, Moshe SL. Early-onset epileptic encephalopathies: Ohtahara syndrome and early myoclonic encephalopathy. Pediatr Neurol. 2012;47(5):317-323. https://doi.org/10.1016/j.pediatrneurol.2012.06.002
Gospe SM Jr. Natural history of pyridoxine-dependent epilepsy: tools for prognostication. Dev Med Child Neurol. 2012;54(9):781-782. https://doi.org/10.1111/j.1469-8749.2012.04354.x
Belousova ED. Epilepsy in inborn errors of metabolism. Epilepsy and paroxysmal conditions. 2016;8(1):55-61. (In Russ.). https://doi.org/10.17749/2077-8333.2016.8.1.055-061
Baulac S, Baulac M. Advances on the genetics of mendelian idiopathic epilepsies. Neurol Clin. 2009;27(4):1041-1061. https://doi.org/10.1016/j.ncl.2009.07.001
Allen NM, Weckhuysen S, Gorman K, et al. Genetic potassium channel-associated epilepsies: Clinical review of the Kv family. Eur J Paediatr Neurol. 2020;24:105-116. https://doi.org/10.1016/j.ejpn.2019.12.002
Bryson A, Petrou S. SCN1A channelopathies: Navigating from genotype to neural circuit dysfunction. Front Neurol. 2023;14:1173460. https://doi.org/10.3389/fneur.2023.1173460
Figueiredo R. C., Rocha, R., Freitas Baptista, C., et al. Dravet Syndrome − experience of a Neuropediatric Unit. Nascer e Crescer — Birth and Growth Medical Journal. 2021;30(4):213-218.
van Hugte EJH, Lewerissa EI, Wu KM, et al. SCN1A-deficient excitatory neuronal networks display mutation-specific phenotypes. Brain. 2023;146(12):5153-5167. https://doi.org/10.1093/brain/awad245
Scheffer IE, Nabbout R. SCN1A-related phenotypes: Epilepsy and beyond. Epilepsia. 2019;60 Suppl 3:S17-S24. https://doi.org/10.1111/epi.16386
Zeng Q, Yang Y, Duan J, et al. SCN2A-Related Epilepsy: The Phenotypic Spectrum, Treatment and Prognosis. Front Mol Neurosci. 2022;15:809951. https://doi.org/10.3389/fnmol.2022.809951
Steel D, Symonds JD, Zuberi SM, et al. Dravet syndrome and its mimics: Beyond SCN1A. Epilepsia. 2017;58(11):1807-1816. https://doi.org/10.1111/epi.13889